5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.

Chou, C-H

5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia. [electronic resource] - Journal of endocrinological investigation Jul 2015 - 799-805 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1720-8386

10.1007/s40618-015-0263-1 doi


5-alpha Reductase Inhibitors--administration & dosage
Acute Coronary Syndrome--chemically induced
Aged
Aged, 80 and over
Case-Control Studies
Drug Therapy, Combination
Dutasteride--administration & dosage
Finasteride--administration & dosage
Humans
Male
Middle Aged
National Health Programs--statistics & numerical data
Odds Ratio
Prostatic Hyperplasia--drug therapy
Risk
Taiwan--epidemiology